These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19376844)

  • 41. An epidemiological study of the effects of statin use on airflow limitation in patients with chronic obstructive pulmonary disease.
    Bando M; Miyazawa T; Shinohara H; Owada T; Terakado M; Sugiyama Y
    Respirology; 2012 Apr; 17(3):493-8. PubMed ID: 22142478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statins and outcome after hospitalization for COPD exacerbation: a prospective study.
    Bartziokas K; Papaioannou AI; Minas M; Kostikas K; Banya W; Daniil ZD; Haniotou A; Gourgoulianis KI
    Pulm Pharmacol Ther; 2011 Oct; 24(5):625-31. PubMed ID: 21729761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Statin use in heart failure: a cause for concern?
    Raina A; Pickering T; Shimbo D
    Am Heart J; 2006 Jul; 152(1):39-49. PubMed ID: 16824830
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preprocedural statin therapy in percutaneous coronary intervention.
    Cahoon WD; Crouch MA
    Ann Pharmacother; 2007 Oct; 41(10):1687-93. PubMed ID: 17712042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins.
    Frost FJ; Petersen H; Tollestrup K; Skipper B
    Chest; 2007 Apr; 131(4):1006-12. PubMed ID: 17426203
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Effect of Statins on Blood Gene Expression in COPD.
    Obeidat M; Fishbane N; Nie Y; Chen V; Hollander Z; Tebbutt SJ; Bossé Y; Ng RT; Miller BE; McManus B; Rennard S; Paré PD; Sin DD
    PLoS One; 2015; 10(10):e0140022. PubMed ID: 26462087
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Statins for infection and sepsis: a systematic review of the clinical evidence.
    Falagas ME; Makris GC; Matthaiou DK; Rafailidis PI
    J Antimicrob Chemother; 2008 Apr; 61(4):774-85. PubMed ID: 18263570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Influence of Prior Statin Use on the Prevalence and Exacerbation of Chronic Obstructive Pulmonary Disease in an Adult Population.
    Kim JH; Choi HG; Kwon MJ; Kim JH; Park JY; Hwang YI; Jang SH; Jung KS
    Front Med (Lausanne); 2022; 9():842948. PubMed ID: 35402450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systematic review of statins for the prevention of vascular dementia or dementia.
    Muangpaisan W; Brayne C;
    Geriatr Gerontol Int; 2010 Apr; 10(2):199-208. PubMed ID: 20100290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effects of statins on mortality in patients with infection: a systematic review].
    Lu XM; Guo FM; Yang Y; Qiu HB
    Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(27):1875-8. PubMed ID: 22093839
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Statin Use in Prostate Cancer: An Update.
    Babcook MA; Joshi A; Montellano JA; Shankar E; Gupta S
    Nutr Metab Insights; 2016; 9():43-50. PubMed ID: 27441003
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical review: Statins and trauma--a systematic review.
    Jansen JO; Lord JM; Thickett DR; Midwinter MJ; McAuley DF; Gao F
    Crit Care; 2013 May; 17(3):227. PubMed ID: 23751018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Statins, vitamin D, and COPD.
    Mascitelli L; Pezzetta F; Goldstein MR
    Chest; 2010 Mar; 137(3):742-3; author reply 743. PubMed ID: 20202968
    [No Abstract]   [Full Text] [Related]  

  • 54. No Independent Influence of Statins on the Chronic Obstructive Pulmonary Disease Exacerbation Rate: A Cohort Observation Study Over 10 Years.
    Yayan J; Bald M; Franke KJ
    Int J Gen Med; 2021; 14():2883-2892. PubMed ID: 34234518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Statins and morbidity and mortality in COPD in the COMIC study: a prospective COPD cohort study.
    Citgez E; van der Palen J; Koehorst-Ter Huurne K; Movig K; van der Valk P; Brusse-Keizer M
    BMJ Open Respir Res; 2016; 3(1):e000142. PubMed ID: 27403321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Geroprotectors as a therapeutic strategy for COPD - where are we now?
    Miłkowska-Dymanowska J; Białas AJ; Makowska J; Wardzynska A; Górski P; Piotrowski WJ
    Clin Interv Aging; 2017; 12():1811-1817. PubMed ID: 29123386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association Between Statin Medications and COPD-Specific Outcomes: A Real-World Observational Study.
    Ajmera M; Shen C; Sambamoorthi U
    Drugs Real World Outcomes; 2017 Mar; 4(1):9-19. PubMed ID: 27943058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Statins as adjunct therapy in COPD: is it time to target innate immunity and cardiovascular risk?
    Young RP; Scott RJ
    Eur Respir J; 2021 Jul; 58(1):. PubMed ID: 34326175
    [No Abstract]   [Full Text] [Related]  

  • 59. Systematic review and meta-analysis on the association between outpatient statins use and infectious disease-related mortality.
    Ma Y; Wen X; Peng J; Lu Y; Guo Z; Lu J
    PLoS One; 2012; 7(12):e51548. PubMed ID: 23284711
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.